Todd Anderman, Chief Legal Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 11,984 shares at $7.29 ($87K) on 2026-10-08, disclosed to the SEC on 2026-10-13.
Open-market sale of $87k OCUL by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.